Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Retrograde signalling by endocannabinoids.

C W Vaughan1, M J Christie

  • 1Pain Management Research Institute, Northern Clinical School, University of Sydney at Royal North Shore Hospital, 2006 NSW, Sydney, Australia.

Handbook of Experimental Pharmacology
|April 7, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phosphorylation-deficient G-protein-biased μ-opioid receptors improve analgesia and diminish tolerance but worsen opioid side effects.

Nature communications·2019
Same author

Themed section.

British journal of pharmacology·2014
Same author

Repeated morphine treatment alters cannabinoid modulation of GABAergic synaptic transmission within the rat periaqueductal grey.

British journal of pharmacology·2014
Same author

β-Arrestin-2 knockout prevents development of cellular μ-opioid receptor tolerance but does not affect opioid-withdrawal-related adaptations in single PAG neurons.

British journal of pharmacology·2014
Same author

Spinal actions of ω-conotoxins, CVID, MVIIA and related peptides in a rat neuropathic pain model.

British journal of pharmacology·2013
Same author

Nucleus accumbens D2- and D1-receptor expressing medium spiny neurons are selectively activated by morphine withdrawal and acute morphine, respectively.

Neuropharmacology·2012
Same journal

Endothelial Cell Phenotypic Plasticity in Atherosclerosis.

Handbook of experimental pharmacology·2026
Same journal

Endothelial Dysfunction and Neurovascular Alterations in Autism Spectrum Disorder.

Handbook of experimental pharmacology·2026
Same journal

Molecular Mechanisms of Endothelial Shear Stress Mechanotransduction in Health and Disease.

Handbook of experimental pharmacology·2026
Same journal

Microvasculature of the Pancreatic Islets of Langerhans in Health and Diabetes.

Handbook of experimental pharmacology·2026
Same journal

Mechanisms of Actions of Physiological, Pharmacological, and Toxicological Dietary Bioactive Inorganic Boron.

Handbook of experimental pharmacology·2026
Same journal

BNCT Plus Luminescence: New Paradigm for Boron-Containing Drug Design.

Handbook of experimental pharmacology·2026
See all related articles

The cannabinoid system uses endocannabinoids to regulate brain signaling. These compounds act retrogradely, selectively reducing synaptic inputs to modulate neuronal activity.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • The cannabinoid system involves G protein-coupled receptors (CB1, CB2), endocannabinoids, and their metabolic pathways.
  • Delta9-tetrahydrocannabinol (THC) from marijuana acts on CB1 receptors to affect neuronal excitability and synaptic transmission.
  • THC inhibits synaptic transmission through presynaptic CB1 receptor mechanisms.

Purpose of the Study:

  • To review the cellular mechanisms of retrograde endocannabinoid signaling.
  • To explain how endocannabinoids modulate synaptic transmission.
  • To detail the role of endocannabinoids in neuronal communication.

Main Methods:

  • Review of existing literature on cannabinoid signaling.
  • Analysis of cellular and molecular mechanisms of endocannabinoid synthesis and action.

Related Experiment Videos

  • Examination of receptor interactions and retrograde signaling pathways.

    • Main Results:

    • Physiological neuronal stimulation induces endocannabinoid synthesis.
    • Endocannabinoids modulate synaptic transmission via CB1 and other receptors.
    • Endocannabinoids function as retrograde signaling agents, selectively reducing synaptic inputs.

    Conclusions:

    • Retrograde endocannabinoid signaling is a key mechanism for regulating synaptic plasticity.
    • Understanding these mechanisms is crucial for deciphering the endocannabinoid system's role in brain function.
    • This review elucidates the cellular basis of retrograde endocannabinoid signaling.